Neurology Devices companies

  • Report ID: 3853
  • Published Date: Aug 04, 2025
  • Report Format: PDF, PPT

Key Neurology Devices Market Players:

    international neurology devices market is effectively dominated by the presence of organizations, such as Boston Scientific, Abbott, and Medtronic, collectively accounting for 65% of the overall market share. This is effectively propelled by AI-powered advancements, along with tactical acquisitions. Besides, firms in Europe, including Siemens Healthineers, have focused on neuroimaging, while companies from Japan, such as Omron and Nihon Kohden, deliberately dominate the APAC region with the existence of affordable diagnostics. Meanwhile, China-based firms, including MicroPort, have challenged incumbents with a USD 550 million investment for research and development, particularly catering to neurovascular technology, thus suitable for proliferating the market globally.

    Here is a list of key players operating in the global market:

    Company Name Compan Market Share (2024) Industry Focus

    Medtronic

    U.S.

    22.6%

    Leader in DBS (Percept PC), spinal cord stimulators, and AI-enabled neurodiagnostics

    Abbott Laboratories

    U.S.

    18.5%

    Neurostimulators (Proclaim SCS), stroke intervention devices

    Boston Scientific

    U.S.

    15.3%

    Vercise DBS systems, embolization coils for aneurysms

    Siemens Healthineers

    Germany

    10.2%

    Advanced MRI/EEG systems, robotic neurosurgery tools

    Stryker

    U.S.

    8.7%

    Neurovascular devices (Trevo stent retrievers)

    Johnson & Johnson (Cerenovus)

    U.S.

    xx%

    Stroke thrombectomy devices, neurovascular stents

    GE Healthcare

    U.S.

    xx%

    Portable EEGs, AI-based neuroimaging solutions

    LivaNova

    UK

    xx%

    Vagus nerve stimulators for epilepsy

    Penumbra

    U.S.

    xx%

    Neurothrombectomy systems (Jet 7)

    Integra LifeSciences

    U.S.

    xx%

    Neurosurgical tools, CSF management devices

    MicroPort Scientific

    China

    xx%

    Neurointerventional devices (APOLLO stent)

    Nevro

    U.S.

    xx%

    HFX spinal cord stimulation for chronic pain

    Natus Medical

    U.S.

    xx%

    Neonatal EEG, neurodiagnostic equipment

    Brainlab

    Germany

    xx%

    Neurosurgical navigation systems, AI-driven planning software

    Cadwell Industries

    U.S.

    xx%

    Portable neuromonitoring devices

    Sources: FDA, SEC, Boston Scientific, Siemens-Healthineers, Stryker, JNJ, GE Healthcare, Liva Nova, Penumbra Inc., Integra-LS, MicroPort, Nevro, Natus, Brainlab, Cadwell, Nihon Kohden, Omron Healthcare, Terumo Corporation, Fukuda Denshi, Mizuho Medical

    Below are the areas covered for each company in the market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the neurology devices market was over USD 13.2 billion.

The market size for the neurology devices market is projected to reach USD 28.7 billion by the end of 2034 expanding at a CAGR of 8.2% during the forecast period i.e., between 2025-2034.

The major players in the market are GE Healthcare, LivaNova, Penumbra, Integra LifeSciences, and others.

In terms of the distribution segment, the direct institutional sales segment is anticipated to garner the largest market share of 45.8% by 2034 and display lucrative growth opportunities during 2025-2034.

The market in North America is projected to hold the largest market share of 42.1% by the end of 2034 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos